FIELD: biotechnology.
SUBSTANCE: presented in the invention are: pharmaceutical compositions containing an antibody against CD40 or an antigen-binding fragment thereof, and an application of said compositions; a lyophilised agent for treating diseases and a method for production thereof; and a kit for treating CD40-associated diseases or symptoms.
EFFECT: possibility of producing pharmaceutical compositions showing good antibody stability and used to effectively treat CD40-associated diseases or symptoms.
19 cl, 16 tbl, 15 ex
             
         
            
              
                | Title | Year | Author | Number | 
							
              
                | PHARMACEUTICAL COMPOSITION CONTAINING ANTIBODIES TO PCSK-9, AND ITS USE | 2018 | 
										Tian, ChenminLi, HaoLiu, Xun | RU2782792C2 | 
							
              
                | PHARMACEUTICAL COMPOSITION CONTAINING ANTIBODY TO LAG-3 AND ITS USE | 2018 | 
										Wu TingtingLi HaoLiu XunFu Yayuan | RU2771384C2 | 
							
              
                | PHARMACEUTICAL COMPOSITION CONTAINING ANTIBODY TO SOST, AND ITS USE | 2018 | 
										Fang JingjingYan ZhenLiu Xun | RU2779430C2 | 
							
              
                | PHARMACEUTICAL COMPOSITION OF THE FUSION PROTEIN OF THE TRANSFORMING GROWTH FACTOR BETA RECEPTOR AND ITS APPLICATION | 2019 | 
										Tyan, ChenminLi, KhaoLyu, Syun | RU2791683C2 | 
							
              
                | PHARMACEUTICAL COMPOSITION BASED ON ANTIBODY TO PD-L1 AND ITS APPLICATION | 2018 | 
										Yan, ZhenYang, JianjianYan, XiaodanWu, ShanLiu, Xun | RU2766590C2 | 
							
              
                | PHARMACEUTICAL COMPOSITION CONTAINING ANTI-IL-5 ANTIBODY, AND USE THEREOF | 2020 | 
										U, TintinLi, KhaoLyu, SyunTao, Vejkan | RU2824390C2 | 
							
              
                | CONJUGATE OF ANTI-CLAUDIN ANTIBODY AND MEDICINAL AGENT AND PHARMACEUTICAL USE THEREOF | 2020 | 
										Yang YangXu JianyanTao Weikang | RU2826119C1 | 
							
              
                | ANTIBODY TO CD40, ITS ANTIGENE-BINDING FRAGMENT AND ITS MEDICAL USE | 2018 | 
										Yan, ShudeJiang, JiahuaHu, QiyueZhang, LianshanCao, GuoqingQian, XuemingTeng, Fei | RU2779128C2 | 
							
              
                | ANTIBODY TO PD-1, ITS ANTIGEN-BINDING FRAGMENT AND ITS PHARMACEUTICAL USE | 2020 | 
										Gu XiaolingYe XinGe HuTao Weikang | RU2807484C2 | 
							
              
                | CONJUGATE OF ANTI-CEA ANTIBODY AND EXCATECAN ANALOGUE AND PHARMACEUTICAL USE THEREOF | 2020 | 
										Ying HuaMao LangyongWang Sijia | RU2833323C1 |